Sector revisions Charles River Laboratories International, Inc. Deutsche Boerse AG

Stocks

Real-time Estimate Tradegate 02:45:30 2026-10-02 pm EDT			5-day change	1st Jan Change
256.85 ^EUR	-1.70%		-1.28%	+48.27%

Sep. 30	UBS Upgrades Charles River Laboratories International to Buy From Neutral, Adjusts Price Target to $357 From $175	MT
Sep. 29	PMGC Unit Working With Charles River Laboratories for Muscle Health Probiotic Testing	MT

Sector:

Location:

X axis:

Main competitors

Add to a list 0 selected To use this feature you must be a member Log in Sign up	1y. EPS revision	Nbr of analysts
WUXI APPTEC CO., LTD.		18
ARGENX SE		15
LONZA GROUP AG		23
IQVIA HOLDINGS INC.		19
REVOLUTION MEDICINES, INC.		22
BEONE MEDICINES AG		28
CELLTRION, INC.		22
WUXI BIOLOGICS (CAYMAN) INC.		24
INSMED INCORPORATED		23
BIONTECH SE		20
GENMAB A/S		15
MEDPACE HOLDINGS, INC.		13
PHARMAESSENTIA CORPORATION		8
ASCENDIS PHARMA A/S	-	20
SICHUAN KELUN-BIOTECH BIOPHARMACEUTICAL CO., LTD.		19
EUROFINS SCIENTIFIC SE		14
TEMPUS AI, INC.		18
EXELIXIS, INC.		15
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.		15
Average		18
Weighted average by Cap.		19